JP Morgan Private Wealth Advisors’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-803
Closed -$47K 1728
2020
Q3
$47K Sell
803
-47
-6% -$3.48K ﹤0.01% 1575
2020
Q2
$95K Sell
850
-192
-18% -$13.7K ﹤0.01% 1516
2020
Q1
$70K Sell
1,042
-7
-0.7% -$705 ﹤0.01% 1377
2019
Q4
$145K Sell
1,049
-37
-3% -$4.8K ﹤0.01% 1424
2019
Q3
$114K Buy
1,086
+339
+45% +$33.8K ﹤0.01% 1389
2019
Q2
$79K Sell
747
-14
-2% -$1.84K ﹤0.01% 1344
2019
Q1
$118K Buy
761
+53
+7% +$6.15K ﹤0.01% 1406
2018
Q4
$66K Buy
+708
New +$101K ﹤0.01% 1414

Other funds holding OPTN

JP Morgan Private Wealth Advisors's OPTN Position: Q4 2020 in Review

JP Morgan Private Wealth Advisors sold out of OptiNose (OPTN) in Q4 2020, closing a stake of 803 shares — an estimated $47K sold.

JP Morgan Private Wealth Advisors first reported a position in OPTN in Q4 2018 and held it in 8 quarters. The position peaked at $145K in Q4 2019. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2020.

  • JP Morgan Private Wealth Advisors reported no remaining OptiNose position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 803 OptiNose shares in Q4 2020, an estimated $47K.
  • JP Morgan Private Wealth Advisors first reported a position in OptiNose in Q4 2018 and held it in 8 quarters.
  • JP Morgan Private Wealth Advisors's OptiNose position peaked at $145K in Q4 2019.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.